| Noncolorectal Gastrointestinal Cancer |
1 |
0.97 |
| Esophageal Cancer |
0 |
0.73 |
| Esophagus |
0 |
0.58 |
| Otolaryngology |
0 |
0.55 |
| Preventive Screening |
0 |
0.52 |
| Cancer |
0 |
0.45 |
| Esophageal Adenocarcinoma |
0 |
0.35 |
| Dysplasia |
0 |
0.32 |
| Endoscopy |
0 |
0.32 |
| Healthcare and Medical Technology |
0 |
0.26 |
| Biomarker |
0 |
0.19 |
| Barrett Esophagus |
0 |
0.17 |
| Adenocarcinoma |
0 |
0.13 |
| Electronic Health Record (EHR) |
0 |
0.09 |
| Electronic Medical Record |
0 |
0.09 |
| Radiofrequency Ablation |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Ablation |
0 |
0.07 |
| Artificial Intelligence |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Financial Reimbursement |
0 |
0.07 |
| Hand |
0 |
0.07 |
| Medical Innovations |
0 |
0.07 |
| Medical Records |
0 |
0.07 |
| Plasma |
0 |
0.07 |
| Prognosis |
0 |
0.07 |
| Proton Pump Inhibitor |
0 |
0.07 |
| Traction |
0 |
0.07 |